Japan-based Takeda Pharmaceutical, which has its ADR listed on the NYSE, gets a buy rating today, agreeing with the analyst consensus. Besides a diverse drug portfolio across multiple segments ...

Evox Therapeutics is the second UK biotech to sign a big deal with a pharma giant this week, snaring an $882 million partnership with Takeda for up to five rare disease programmes. The alliance ...

Three years after it was formed as a spinout of Japanese drugmaker Takeda, Phathom Pharmaceuticals has racked up its first FDA approvals, and claimed a sizeable $260 million in new financing to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The S&P 500 has sunk to the start of 2025. But most Wall Street strategists argue there's likely still more upside for stocks to end the year. Chinese technology giant Baidu released two new ...

Sarah Kellam is a Kentucky native and played collegiate golf at Northern Kentucky University. She currently serves as a Manager of Digital Content and prior to the LPGA, Sarah worked as a ...

After hours: March 14 at 7:37:58 PM EDT Loading Chart for TAK ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

The Winter 2025 Anime Preview Guide - Aquarion: Myth of Emotions (Jan 9, 2025) The Winter 2025 Anime Preview Guide - Honey Lemon Soda (Jan 7, 2025) ...